2023
DOI: 10.1093/bib/bbad194
|View full text |Cite
|
Sign up to set email alerts
|

DCiPatho: deep cross-fusion networks for genome scale identification of pathogens

Abstract: Pathogen detection from biological and environmental samples is important for global disease control. Despite advances in pathogen detection using deep learning, current algorithms have limitations in processing long genomic sequences. Through the deep cross-fusion of cross, residual and deep neural networks, we developed DCiPatho for accurate pathogen detection based on the integrated frequency features of 3-to-7 k-mers. Compared with the existing state-of-the-art algorithms, DCiPatho can be used to accuratel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…Deep cross-fusion networks for genome-scale identification of pathogens (DCiPatho) for toxicity prediction of bacteria were used to assess the pathogenicity of differentially relative abundant microbes [57]. DCiPatho is a tool for predicting pathogenic microbial genes within the microbiota by analyzing gene toxicity, thus assisting in identifying potential microbial biomarkers (https://github.com/LorMeBioAI/DCiPatho, accessed on 20 September 2023).…”
Section: Core Microbial Biomarker and Enterotype Analysismentioning
confidence: 99%
“…Deep cross-fusion networks for genome-scale identification of pathogens (DCiPatho) for toxicity prediction of bacteria were used to assess the pathogenicity of differentially relative abundant microbes [57]. DCiPatho is a tool for predicting pathogenic microbial genes within the microbiota by analyzing gene toxicity, thus assisting in identifying potential microbial biomarkers (https://github.com/LorMeBioAI/DCiPatho, accessed on 20 September 2023).…”
Section: Core Microbial Biomarker and Enterotype Analysismentioning
confidence: 99%